Amanote Research
Register
Sign In
Epidermal Growth Factor Receptor Antibody Plus Recombinant Human Endostatin in Treatment of Hepatic Metastases After Remnant Gastric Cancer Resection
World Journal of Gastroenterology
- China
doi 10.3748/wjg.13.6115
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Gastroenterology
Date
January 1, 2007
Authors
Long Sun
Publisher
Baishideng Publishing Group Inc.
Related search
Epidermal Growth Factor Receptor Structural Alterations in Gastric Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Expression of Growth Factor Receptor Family Before and After Targeted Therapy in Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Tissues
Korean Journal of Clinical Oncology
Epidermal Growth Factor Receptor in Human Glioma
Journal of Neurosurgery
Surgery
Neurology
Hypermethylated Epidermal Growth Factor Receptor (EGFR) Promoter Is Associated With Gastric Cancer
Scientific Reports
Multidisciplinary
Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer
Expert Opinion on Biological Therapy
Drug Discovery
Clinical Biochemistry
Pharmacology
Targeting the Human Epidermal Growth Factor Receptor 2 in Esophageal Cancer
Cancer Control
Medicine
Oncology
Hematology
Management of Brain Metastases in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer
Frontiers in Oncology
Cancer Research
Oncology
Treatment of Pancreatic Cancer With Epidermal Growth Factor Receptor-Targeted Therapy
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
A Meta-Analysis of Oestrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Discordance Between Primary Breast Cancer and Metastases
European Journal of Cancer
Cancer Research
Oncology